Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Affimed N.V. (AFMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 273,892
  • Shares Outstanding, K 62,390
  • Annual Sales, $ 2,270 K
  • Annual Income, $ -34,160 K
  • 36-Month Beta 3.62
  • Price/Sales 117.03
  • Price/Cash Flow N/A
  • Price/Book 6.38

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.17
  • Number of Estimates 3
  • High Estimate -0.14
  • Low Estimate -0.21
  • Prior Year -0.16
  • Growth Rate Est. (year over year) -6.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.87 +49.13%
on 10/30/18
4.69 -8.74%
on 11/19/18
+1.07 (+33.33%)
since 10/19/18
3-Month
1.55 +176.13%
on 08/27/18
7.35 -41.77%
on 08/29/18
+2.68 (+167.50%)
since 08/20/18
52-Week
1.15 +272.17%
on 12/21/17
7.35 -41.77%
on 08/29/18
+2.23 (+108.78%)
since 11/20/17

Most Recent Stories

More News
Report: Exploring Fundamental Drivers Behind Affimed N.V, Sensus Healthcare, Lifetime Brands, SigmaTron International, Salem Media Group, and Origin Agritech -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Affimed N.V. (NASDAQ:AFMD),...

AFMD : 4.28 (-2.51%)
LCUT : 11.01 (+1.94%)
SEED : 7.72 (-4.69%)
SRTS : 5.80 (-1.36%)
SALM : 2.85 (-3.39%)
SGMA : 3.99 (-5.45%)
SRTSU : 6.45 (-0.77%)
Implied Volatility Surging for Affimed (AFMD) Stock Options

Affimed (AFMD) needs investors to pay close attention to the stock based on moves in the options market lately.

AFMD : 4.28 (-2.51%)
Affirmed Therapeutics (AFMD) Reports Q3 Loss, Tops Revenue Estimates

Affirmed Therapeutics (AFMD) delivered earnings and revenue surprises of -29.41% and 18.67%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?...

AFMD : 4.28 (-2.51%)
What's in the Cards for BioSpecifics (BSTC) in Q3 Earnings?

On BioSpecifics' (BSTC) Q3 conference call, investor focus will be on its progress with the development of CCH for treating uterine fibroids.

AFMD : 4.28 (-2.51%)
ENDP : 12.53 (+0.56%)
FGEN : 39.38 (+0.43%)
BSTC : 56.22 (-3.73%)
Rockwell Automation (ROK) Q4 Earnings: A Beat in the Offing?

Rockwell Automation's (ROK) Q4 performance will be supported by accelerated investments and higher backlogs despite weakness in Transportation vertical and tariff woes.

AFMD : 4.28 (-2.51%)
ADM : 45.66 (-1.40%)
AES : 14.90 (-3.12%)
ROK : 168.23 (+0.11%)
Tenet Healthcare (THC) Q3 Earnings: What's in the Cards?

Tenet Healthcare's (THC) third quarter earnings is likely to gain from solid performance by the Conifer Segment

HUM : 307.22 (-1.02%)
AFMD : 4.28 (-2.51%)
ALNY : 72.66 (+1.65%)
THC : 21.82 (-2.68%)
Molina Healthcare's (MOH) Q3 Earnings: Is a Beat in Store?

Molina Healthcare (MOH) is likely to perform well in the third quarter on the back of a solid Medicaid business and its operational excellence.

HUM : 307.22 (-1.02%)
AFMD : 4.28 (-2.51%)
MOH : 120.55 (+1.98%)
ALNY : 72.66 (+1.65%)
Company News For Oct 10, 2018

Companies in the news are: PZZA, MSFT, AFMD and SBUX

MSFT : 101.71 (-2.78%)
AFMD : 4.28 (-2.51%)
PZZA : 58.19 (+1.36%)
SBUX : 67.18 (-1.07%)
Affimed Down After Clinical Hold on Two Early-Stage Studies

Affimed (AFMD) puts two phase I studies evaluating its CD19/CD3-targeting T cell engager, AFM11, on clinical hold due to one death and two life-threatening events.

AFMD : 4.28 (-2.51%)
RHHBY : 30.9500 (-0.10%)
CSBR : 10.35 (+1.57%)
BSTC : 56.22 (-3.73%)
Implied Volatility Surging for Affimed (AFMD) Stock Options

Investors need to pay close attention to Affimed (AFMD) stock based on the movements in the options market lately.

AFMD : 4.28 (-2.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade AFMD with:

Business Summary

Affimed Therapeutics B.V. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology. The Company's TandAbs has the ability to bring NK-cells or T-cells into proximity and...

See More

Key Turning Points

2nd Resistance Point 4.70
1st Resistance Point 4.49
Last Price 4.28
1st Support Level 4.05
2nd Support Level 3.82

See More

52-Week High 7.35
Fibonacci 61.8% 4.98
Last Price 4.28
Fibonacci 50% 4.25
Fibonacci 38.2% 3.52
52-Week Low 1.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar